San Francisco, 19 December 2018, Cell Line Development Market Size, Share & Trends Analysis Report
by Product, By Source (Mammalian, Non-Mammalian), By Type of Cells, By
Application, By Technology, And Segment Forecasts, 2012 – 2022
Global cellline development market size is expected to reach USD 6.24 billion by 2022,
according to a new report by Grand View Research, Inc. The Increasing demand
for monoclonal antibodies and patent expiration of blockbuster biologics are
expected to drive the cell line development industry over the forecast period.
Increasing prevalence of
autoimmune diseases and cancer are likely to increase the demand for accurate
and cost effective treatment options which is expected to render a positive
impact on market growth. In addition, improving healthcare infrastructure,
economic development and favorable government initiatives promoting the growth
of the biotechnology industry are factors contributing towards the growth of
the cell line development market.
Ongoing R&D for stable
& authentic cell lines and the introduction of technologically advanced
processes such as single use bioreactor and micro bioreactor for large scale
bioproduction are further expected to provide this market with lucrative future
growth opportunities.
Access Full Research
Report On Cell Line Development Market Analysis:
Further key findings from the study suggest:
·
Reagent and media was the
largest product market in 2014, owing to increasing number of cell culture
procedures. Reagent and media are necessary components involved in cell line
development procedures & cell culture and are cost intensive in nature. The
market for reagent and media was valued at over 1.0 billion in 2014.
·
Mammalian cell lines were
widely used as a source for cell line development in 2014, owing to associated
advantages such as accurate complex protein expression nature, critical for the
production of monoclonal antibodies, vaccines, and biologics.
·
Cell line development finds the
largest application in the bioproduction of biologics, vaccines, Mabs,
therapeutic proteins and biosimilars. Rising demand for monoclonal antibodies
and vaccines are expected to boost the growth of this segment over the forecast
period. The market for cell line development based bioproduction is also
expected to witness lucrative growth of over 12.5% during the forecast period.
·
North America was the largest
market in 2014, with revenue estimated at over 800 million. The region’s market
dominance is attributed to factors such as the growing adoption rates of cell
culture techniques, presence of well developed healthcare infrastructure,
supportive government initiatives and high healthcare expenditure levels.
·
Asia Pacific cell line development
market is anticipated to register rapid growth over the forecast period owing
to factors such as the presence of high unmet needs, rising number of CROs
(Contract Research Organization) providing pertinent services, growing R&D
investments aimed at the development of stable cell lines and increasing
biologics production.
·
Key players in this market
include European Collection of cell Cultures (ECACC), Lonza Group AG, GE
Healthcare, Thermo Fisher Scientific Inc., Sartorious AG, Selexis SA, Wuxi
AppTec Inc., Sigma-Aldrich Corporation, American Type Culture Collection (ATCC)
and Corning Inc.
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the
global cell line development market on the basis of product, source, type of
cell line, application and region:
Global Cell Line Development
Product Outlook (Revenue, USD Million, 2012 - 2022)
o
Reagents and media
o
Equipment Accessories and
consumables
o
Incubators
o
Centrifuges
o
Bioreactors
o
Storage equipment
o
Microscopes
Global Cell Line Development
Source Outlook (Revenue, USD Million, 2012 - 2022)
o
Mammalian
o
Non mammalian
o
Insects
o
Amphibians
Global Cell Line Development
Type Of Cell Line Outlook (Revenue, USD Million, 2012 - 2022)
o
Recombinant cell lines
o
Hybridomas
o
Continuous cell line
o
Primary cell lines
Global Cell Line Development
Application Outlook (Revenue, USD Million, 2012 - 2022)
o
Bioproduction
o
Drug discovery
o
Toxicity testing
o
Tissue engineering
o
Research
Cell Line Development Regional
Outlook (Revenue, USD Billion, 2014 - 2022)
o
North America
o
U.S.
o
Canada
o
Europe
o
Germany
o
UK
o
Asia Pacific
o
China
o
Japan
o
India
o
Latin America
o
Mexico
o
Brazil
o
MEA
o
South Africa
Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-cell-line-development-market
www.grandviewresearch.com/press-release/global-cell-line-development-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information: www.grandviewresearch.com/